Search Results - "FRITZER, M"

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity by Mandorfer, M., Schwabl, P., Paternostro, R., Pomej, K., Bauer, D., Thaler, J., Ay, C., Quehenberger, P., Fritzer‐Szekeres, M., Peck‐Radosavljevic, M., Trauner, M., Reiberger, T., Ferlitsch, A.

“…Summary Background Elevated plasma von Willebrand factor antigen (vWF) has been shown to indicate the presence of clinically significant portal hypertension,…”
Get full text

A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection by Schmidt, R.L.J., Simon, A., Popow-Kraupp, T., Laggner, A., Haslacher, H., Fritzer-Szekeres, M., Redlberger-Fritz, M., Mayer, F.J.

“…The aim of this single-centre study was the comparative analysis of the GeneXpert (Cepheid Inc.) and the LIAT (Roche) system for the rapid polymerase chain…”
Get full text

Long-term endurance training increases serum cathepsin S levels in healthy female subjects by Sponder, M., Minichsdorfer, C., Campean, I.-A., Emich, M., Fritzer-Szekeres, M., Litschauer, B., Strametz-Juranek, J.

“…Background Circulating cathepsin S (CS) has been associated with a lower risk for breast cancer in a large Swedish cohort. Long-term physical activity has been…”
Get full text

Quality management in medical laboratories by Fritzer-Szekeres, M

“…During the 20th century understanding for quality has changed and international and national requirements for quality have been published. Therefore also…”
Get more information

A global MHD solar wind model with WKB Alfvén waves: Comparison with Ulysses data by Usmanov, Arcadi V., Goldstein, Melvyn L., Besser, Bruno P., Fritzer, Johannes M.

“…We use a steady state global axisymmetric MHD model to reproduce quantitatively the Ulysses observations during its first fast latitude traversal in 1994–1995…”
Get full text

The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels by KERB, R, AYNACIOGLU, A. S, GÜZELBEY, P, ROOTS, I, BRINKMANN, U, BROCKMÖLLER, J, SCHLAGENHAUFER, R, BAUER, S, SZEKERES, T, HAMWI, A, FRITZER-SZEKERES, M, BAUMGARTNER, C, ÖNGEN, H. Z

“…Phenytoin, an anticonvulsant, exhibits nonlinear pharmacokinetics with large interindividual differences. Because of its small therapeutic range with the risk…”
Get full text

Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes by Resl, M, Clodi, M, Vila, G, Luger, A, Neuhold, S, Wurm, R, Adlbrecht, C, Strunk, G, Fritzer-Szekeres, M, Prager, R, Pacher, R, Hülsmann, M

“…We hypothesised that biomarkers representing different pathophysiological pathways of atherosclerosis namely growth differentiation factor 15 (GDF-15),…”
Get more information

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo by CEJKA, D, KUNTNER, C, MUELLER, M, LANGER, O, WACHECK, V, PREUSSER, M, FRITZER-SZEKERES, M, FUEGER, B. J, STROMMER, S, WERZOWA, J, FUEREDER, T, WANEK, T, ZSEBEDICS, M

Get full text

Endostatin and physical exercise in young female and male athletes and controls by Sponder, M, Sepiol, K, Lankisch, S, Priglinger, M, Kampf, S, Litschauer, B, Fritzer-Szekeres, M, Strametz-Juranek, J

“…It was suggested that endostatin, an angiogenic mediator, is influenced by physical exercise. We performed bicycle stress testing in 88 healthy non-smoking…”
Get more information

Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro by Madlener, S, Saiko, P, Vonach, C, Viola, K, Huttary, N, Stark, N, Popescu, R, Gridling, M, Vo, N T-P, Herbacek, I, Davidovits, A, Giessrigl, B, Venkateswarlu, S, Geleff, S, Jäger, W, Grusch, M, Kerjaschki, D, Mikulits, W, Golakoti, T, Fritzer-Szekeres, M, Szekeres, T, Krupitza, G

“…Background: Digalloyl-resveratrol (di-GA) is a synthetic compound aimed to combine the biological effects of the plant polyhydroxy phenols gallic acid and…”
Get full text

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo by Cejka, D, Kuntner, C, Preusser, M, Fritzer-Szekeres, M, Fueger, B J, Strommer, S, Werzowa, J, Fuereder, T, Wanek, T, Zsebedics, M, Mueller, M, Langer, O, Wacheck, V

“…This study aimed to test whether [ 18 F]fluoro- D -glucose (FDG) uptake of tumours measured by positron emission tomography (PET) can be used as surrogate…”
Get full text

Hemostasis activation in patients with liver cirrhosis by Vukovich, Th, Teufelsbauer, H., Fritzer, M., Kreuzer, S., Knoflach, P.

“…In patients with liver cirrhosis a decrease of the coagulant potential is well-documented and has been linked to the high bleeding tendency among these…”
Get full text

Amidox, an Inhibitor of Ribonucleotide Reductase, Potentiates the Action of Ara-C in HL-60 Human Promyelocytic Leukemia Cells by Bauer, W., Horvath, Z., Höchtl, T., Saiko, P., Karl, D., Fritzer-Szekeres, M., Szekeres, T.

“…Amidox (3,4-dihydroxybenzamidoxime), a new polyhydroxy-substituted benzoic acid derivative, is a potent inhibitor of the enzyme ribonucleotide reductase (RR),…”
Get full text

9217 POSTER Epigallocatechin Gallate Inhibits Ribonucleotide Reductase in Human HL-60 Promyelocytic Leukemia Cells by Saiko, P, Graser, G, Schwarz, S, Lackner, A, Grusch, M, Krupitza, G, Jaeger, W, Fritzer-Szekeres, M, Szekeres, T

Get full text

Cytotoxic and Apoptotic Effects of Novel Heterodinucleoside Phosphates Consisting of 5-Fluorodeoxyuridine and Ara-C in Human Cancer Cell Lines by Saiko, P., Bauer, W., Horvath, Z., Hoechtl, T., Grusch, M., Illmer, C., Madlener, S., Krupitza, G., Mader, R. M., Schott, H., Fritzer-Szekeres, M., Szekeres, T.

“…In search for possible alternatives in the treatment of human malignancies we investigated several new heterodinucleoside phosphates containing of…”
Get full text

Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver by Salamon, A, Vielnascher, E, Hagenauer, B, Szekeres, T, Szekeres-Fritzer, M, Thalhammer, T, Jäger, W

“…Amidox (AX) is a novel anticancer drug currently undergoing pre-clinical studies. Though AX shows activity against various tumor cells, its biotransformation…”
Get more information

Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells by SKEKERES, T, FRITZER, M, STROBL, H, GHAREHBAGHI, K, FINDENIG, G, ELFORD, H. L, LHOTKA, C, SCHOEN, H. J, JAYARAM, H. N

“…Increased ribonucleotide reductase (RR) activity has been linked with malignant transformation and tumor cell growth. Therefore, this enzyme is considered to…”
Get full text

Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH) by FIEGL, M, MASSONER, A, HAUN, M, STURM, W, KAUFMANN, H, HACK, R, KRUGMANN, J, FRITZER-SZEKERES, M, GRÜNEWALD, K, GASTL, G

“…Diagnosis of malignant cells in effusions is important for staging procedures and resulting therapeutic decisions. Cytodiagnostics in effusions is sometimes…”
Get full text

Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC by Maier, S, Strasser, S, Saiko, P, Leisser, C, Sasgary, S, Grusch, M, Madlener, S, Bader, Y, Hartmann, J, Schott, H, Mader, R M, Szekeres, T, Fritzer-Szekeres, M, Krupitza, G

“…Chemoresistance is a biological response of cells to survive toxic stress. During cancer treatment the development of chemoresistance is a major problem. The…”
Get full text

Elevated high-sensitivity C-reactive protein and the risk for cardiovascular events in chronic cardiac disease by Han, E, Fritzer-Szekeres, M, Szekeres, T, Gehrig, T, Gyongyosi, M, Bergler-Klein, J

“…Abstract Background High sensitivity C-reactive protein (hs-CRP) is a biomarker used for risk prediction for cardiovascular disease by assessing low…”
Get full text